Pricing Log in Create free account

Cocrystal Pharma, Inc. (COCP) vs Quantum Biopharma Ltd. (QNTM)

Cocrystal Pharma, Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. Quantum Biopharma Ltd. is the larger, with a market value of $21.9M against $19.8M — 1.1× the size. Quantum Biopharma Ltd. has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Cocrystal Pharma, Inc. leads on 8 and Quantum Biopharma Ltd. on 6.

Valuation

Metric COCP QNTM Biotechnology median
P/E n/m n/m 8.50
P/S 10.58 70.87 9.71
P/B 13.47 2.70 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.90 28.83 9.21
Earnings yield (74.51%) (222.27%) (33.15%)
Free cash flow yield (56.64%) (55.14%) (25.50%)

Profitability

Metric COCP QNTM Biotechnology median
Gross margin 9.10% 0.00% 65.16%
Operating margin (760.72%) 0.00% 0.00%
Net margin (747.78%) 0.00% 0.00%
Free cash flow margin (598.50%) 0.00% 0.00%
Return on equity (311.68%) (618.06%) (56.36%)
Return on assets (151.10%) (169.48%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COCP QNTM Biotechnology median
Revenue growth (TTM) (30.38%) — 6.02%
EPS growth (last fiscal year) 54.65% 37.50% 30.26%
Revenue growth, 5-year CAGR (33.30%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP QNTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.24 1.20 4.72
Net debt to EBITDA 0.82 0.31 0.96

Dividend

Metric COCP QNTM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COCP QNTM Biotechnology median
Market cap 19.84m 21.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack